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Introduction
The role of the T cell in initiating or perpetuating chronic
inflammation is unknown. Juvenile idiopathic arthritis (JIA)
encompasses a heterogeneous group of chronic inflamma-
tory diseases, characterised by persistent arthritis beginning
before the age of 16 years. It is classified into subgroups
according to associated clinical features [1]. In several sub-
groups of JIA, there is indirect evidence that infectious
agents play a role in either initiation or perpetuation of the
inflammatory process [2–4], but the role of one or more
intra-articular antigens in contributing to the observed
expansion of synovial T-cell numbers is unclear [5–7].
Previous research has shown that synovial T cells in JIA
appear to have an activated memory phenotype [8–12],
but only one study has addressed the role of in situ prolif-
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eration in contributing to this phenotype [13]. We hypoth-
esized that a proportion of T cells from the synovial fluid
(SF) of patients with JIA were activated in situ by antigen-
driven cell cycling. Such T cells would be expected to
demonstrate a memory phenotype (CD45RO+) with
markers of recent activation and impending or recently
completed division, in particular CD69, CD71 and CD25.
We also proposed that the differences in disease patho-
genesis between JIA subgroups would be reflected in dif-
ferent patterns of T-cell phenotype and activation status.
Patients and methods
Patients
Forty-four paired samples of SF and peripheral blood (PB)
were obtained during therapeutic arthrocentesis (for intra-
articular corticosteroid administration) from 31 patients
who fulfilled criteria for the diagnosis of JIA (Table 1).
Samples were collected from 12 patients on two separate
occasions and from one patient on three occasions.
Ethical approval for the study was obtained from the local
research ethics committee and all patients and parents (as
appropriate) gave their informed consent for sampling of
SF and PB.
Isolation of mononuclear cells
Mononuclear cells (MCs) were isolated from SF and PB
by the standard method of ficoll (Amersham Pharmacia
Biotech, Sweden) density centrifugation [9].
Flow cytometry
Three-colour staining of MCs was carried out using a stan-
dard protocol [9]. The antibodies used were CD4-BIO,
CD8-BIO, CD25-FITC, CD69-FITC and HLA-DR-FITC
(Becton Dickinson, Oxford, UK); CD71-FITC, CD45RB-
FITC, CD45RO-FITC and CD3-PE (Dako Ltd, Bucks, UK).
Immunofluorescence was detected using a Beckman-
Coulter flow cytometer (Bucks, UK). Dead cells were
excluded by gating on forward/side scatter and T cells
were selected by gating CD3+ cells. Marker expression
was recorded as either percentage of positive cells (%
positive), if there was little overlap between the marked
cell population and the control, or as median fluorescence
intensity (MFI) if there was significant overlap between the
two populations. Because of variation in the numbers of
cells isolated from SF and PB, it was not possible to stain
each sample using the full range of monoclonal antibodies
(as noted in figures and tables).
Cell-cycle analysis
At least 5 × 106 MCs were analysed from PB and SF of
five patients (two with psoriatic arthritis, two with pol-
yarthritis and one with oligoarthritis). Cells were fixed in
70% ethanol for 24 hours. After washing, the cells were
stained with propidium iodide for 30 min at 4°C. Staining
was again detected on a Beckman-Coulter flow cytometer
and data were analysed on WinMDI version 2.5 in accor-
dance with ‘Cell-cycle analysis: a pragmatic approach’
(hoy@cf.ac.uk). Cells were gated to exclude dead cells,
doublets and triplicates.
Culture conditions
We attempted to upregulate expression of activation
markers on T cells from PB by exposing them to a
microenvironment similar to that found in the synovial com-
partment. T cells were cultured overnight in a 1:2 dilution
of autologous, preservative-free and fetal-calf-serum-free
SF with or without hypoxic conditions (95% nitrogen 5%
CO2) for 24 hours, and with or without 200 ng/ml IL-16
(Serotec, Oxford, UK) for 48 hours.
Statistical analysis
Statistical analysis was performed using GraphPad prism
software. Mann–Whitney tests and Wilcoxon t tests were
performed where appropriate.
Table 1
Clinical features of the patients with juvenile idiopathic arthritis (n = 31)
Mean age of  Mean duration of  B27+ ANA+
Subclass of arthritis No. of patients F:M onset (range) (years) disease (range) (years) (no.) (no.)
Oligoarthritis 8 5:3 4.5 (1–13.8) 4.1 (0.3–8) 1 4
Extended oligoarthritis 2 1:1 6.8 (4.5–9) 3.6 (1.2–6) 0 0
Systemic arthritis 2 0:2 6 (2.5–9.6) 6.7 (0.4–13) 0 0
Psoriatic arthritis 8 4:4 7.6 (1.1–10.8) 5.6 (0.5–14.2) 2 6
Enthesitis-related arthritis 4 1:3 11.3 (7.7–12.7) 1.7 (0.1–4) 3 1
Polyarthritis RF– 5 2:3 6.8 (2–13) 1.9 (0.4–4.5) 1 3
Polyarthritis RF+ 1 1:0 13.9 1 0 0
Other 1 0:1 12.9 0.2 0 0
ANA = antinuclear antibodies; F = female; M = male; RF = rheumatoid factor.Results
T-cell activation state
A greater proportion of T cells from SF expressed activa-
tion markers than of T cells from PB (Figs 1a and 2a). The
greatest differences were seen for CD69 (MFI for T cells
from SF and PB 13.2 and 2.7, respectively; P = 0.0002)
and HLA-DR (MFI for SF and PB cells 19.8 and 2.9,
respectively;  P < 0.0001). CD25 and CD71 were also
significantly increased in the SF T-cell population (respec-
tive SF:PB MFI 4.1:3.3 and 3.7:2.7), but the differences
between SF and PB were not as dramatic as for CD69 or
HLA-DR. CD8 T cells expressed significantly higher levels
of CD69 and HLA-DR than did CD4 T cells, whereas
expression of CD25 and CD71 was higher on CD4 than
CD8 T cells (Table 2).
Cell-cycle status
The majority of the SF MCs were in phase G0/G1, with
fewer than 1% in S phase (Fig. 3). There were no
detectable differences in the percentage of dividing SF
cells in comparison with cells from the PB compartment or
between different disease subgroups (data not shown).
Lack of influence on T-cell phenotype of two
microenvironmental factors, hypoxia and IL-16
In the absence of T-cell proliferation, we hypothesized that
factors within the synovial microenvironment, such as
hypoxia, which may induce the expression of the CD71
gene [14,15], or IL-16, which is thought to upregulate
CD25 expression [16], would influence the state of the
T cells. The expression of activation markers on T cells
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Figure 1
Expression of activation and differentiation markers on T cells from peripheral blood (PB) and synovial fluid (SF) of a patient with juvenile idiopathic
arthritis. (a) Expression of activation markers. (b) Expression of differentiation markers. Each histogram is a representative example of marker
expression on PB or the paired SF sample. Marker expression was recorded as either percentage positive cells (CD45RO only), or as median
fluorescent intensity (all other markers). The clear peak on each histogram represents the staining from an isotype-matched, negative control. 
FITC = fluoroscein isothiocyanate; MFI = median fluorescence intensity.Arthritis Research    Vol 4 No 3 Black et al.
Figure 2
Phenotype of peripheral blood (PB) and synovial fluid (SF) T cells from
patients with juvenile idiopathic arthritis. (a) Expression of activation
markers. (b) Expression of differentiation markers. Bars represent
median expression on paired PB and SF samples. Because of variation
in cell numbers isolated from each sample, not all samples could be
stained for every antibody available. Each datum point represents an
individual sample (n = number of samples studied). MFI = median
fluorescence intensity.
Table 2
Expression of activation and differentiation markers on T cells
(CD3+) from peripheral blood (PB) and synovial fluid (SF) of
patients with juvenile idiopathic arthritis
CD4 CD8
Marker PB SF PB SF
CD69 2.8 9.1*** 3.5 14.6***
CD25 3.7 6.0*** 2.9 3.3*
CD71 2.8 5.0*** 3.1 3.9**
HLA-DR 2.7 19.3*** 3.5 26.7***
CD45RO 27.1 97.1*** 23.6 73.9***
CD45RB 179.4 49.1*** 273.8 142.0***
Values are median fluorescence intensity of the markers (except for
CD45RO, which is expressed as % positive) on CD4+ or CD8+
T cells. *P < 0.05, **P < 0.01, ***P < 0.001, versus PB.
Figure 3
Cell-cycle analysis of mononuclear cells from synovial fluid. 
(a) Representative example from a patient with oligoarthritis. 
(b) Positive control: peripheral blood mononuclear cells stimulated
with phytohaemagglutinin for 3 days.from PB was unaffected by culture in the presence of
autologous, cell-free SF under normal or hypoxic condi-
tions. Culture of PB T cells for 48 hours in the presence of
IL-16 did not influence activation marker expression (data
not shown).
T-cell differentiation status
The SF T-cell population consisted mainly of highly differ-
entiated memory cells: 78.9% expressed CD45RO, com-
pared with 24.4% in the PB (P < 0.0001). This was
reflected in the reduced expression of CD45RB on SF
T cells (SF MFI 90.6, PB MFI 207.5; P < 0.0001) (Figs 1b
and 2b).
CD8+ T-cell numbers were higher (SF 45.3%, PB 29.4%,
P < 0.0001) and CD4+ T cells lower (SF 39.9%, PB
58.3%,  P < 0.0001) in SF than in PB. Interestingly,
expression of CD45RO was significantly higher on SF
CD4 T cells than on SF CD8 T cells (97.1% and 73.9%,
respectively). Similarly, expression of CD45RB was lower
on SF CD4 than on CD8 T cells (MFI 49.1 and 142,
respectively) (Table 2).
Clinical parameters
No consistent variation of T-cell activation or differentiation
status was observed for most of the clinical parameters
(Table 3). There was, however, an association between
CD71 expression on SF T cells and the vigour of the
acute-phase response as measured by the erythrocyte
sedimentation rate (P = 0.0005; Fig. 4).
Discussion
In the chronic inflammatory process of JIA, it is unclear
whether the observed accumulation of synovial T cells
reflects local activation by one or more intra-articular anti-
gens or reflects non-antigen-specific migration of memory
T cells into the joint. To address this issue, we compre-
hensively studied the numbers of differentiated, activated
and cycling cells within the SF compartment in JIA.
In the JIA population studied, expression of all the activa-
tion markers on T cells was higher in cells from SF than
Available online http://arthritis-research.com/content/4/3/177
Table 3
Synovial fluid T-cell expression of differentiation and activation markers in disease subgroups of patients with juvenile idiopathic
arthritis
SF T cells Oligo Poly JPsA B27– B27+ ANA– ANA+ APR hi APR lo Drugs+ Drugs–
CD69 10.1 15.8 13.4 14.3 11.8 13.1 15.8 14.4 8.9 14.6 14.3
CD25 3.9 3.9 4.4 4.2 3.6 4.2 3.9 4.0 4.2 4.2 4.0
CD71 3.5 3.4 4.5 3.7 3.5 3.7 3.6 3.8 3.2* 3.7 3.7
HLA-DR 13.1 33.5 30.2 20.5 11.8 18.9 47.4 16.0 19.6 19.2 30.2
CD45RO 74.6 78.8 81.1 77.8 80.1 76.4 78.9 78.9 77.8 77.3 79.0
CD45RB 78.4 88.8 92.2 89.4 106.7 88.3 89.8 85.1 89.8 92.2 69.9
All values represented as median fluorescence intensity (MFI) except CD45RO, which is represented as median % positive. Patients were grouped
according to disease subgroup (oligoarthritis, polyarthritis or psoriatic arthritis), and expression or absence of HLA-B27, ANA, a high or low acute-
phase response (high: erythrocyte sedimentation rate >20 or C-reactive protein >5), and whether they had received intra-articular triamcinolone
hexacetonide earlier in their disease process (drugs+ versus drugs–). There was a statistically significant difference between those groups of
patients with a high or low APR (*P < 0.05). ANA = antinuclear antibodies; APR = acute-phase response; hi = high; lo = low; JPsA = juvenile
psoriatic arthritis; Oligo = oligoarthritis; Poly = polyarthritis.
Figure 4
Relation between erythrocyte sedimentation rate and expression of
CD71 on T cells from synovial fluid from patients with juvenile
idiopathic arthritis. Points represent individual synovial fluid samples.
Data show line of linear regression (P = 0.0005). ESR = erythrocyte
sedimentation rate; MFI = median fluorescence intensity.than in cells from PB. Although this observation has been
reported previously using CD25 and HLA-DR expression
[9–13], the use of the very early activation marker (CD69)
and the transferrin receptor (CD71) in our study has
added an extra dimension to the understanding of the
process of JIA. Antigen-induced T-cell activation in vitro is
known to result in the expression of activation markers in
an orderly sequence: CD69, CD25, CD71 and HLA-DR
[17,18]. In our study, the upregulation of CD69 and HLA-
DR appeared greater than that of CD25 or CD71, sug-
gesting that these changes were not the result of
antigen-specific activation. A similar T-cell activation
pattern has been reported in adults with rheumatoid arthri-
tis [19,20]. Expression of CD69 may be the result of
cell–cell contact after transendothelial migration into the
joint [20,21], and expression of HLA-DR does not neces-
sarily imply recent activation, as it may persist on memory
T cells [22].
To further elucidate whether the expression of activation
markers was induced by T-cell proliferation, we measured
propidium iodide staining of SF T cells. The majority of the
SF MCs were in phase G0/G1, and fewer than 1% were in
S phase. MC proliferation was no greater in SF than in PB,
confirming the observations Bergroth et al. made by a
manual count of 3H-thymidine-labelled MCs in SF [13].
This finding suggests that SF T cells in JIA express activa-
tion markers as a result of a proliferation-independent
process. It is possible, however, that actively proliferating
cells were lost during the cell-separation process. It is also
possible that small numbers of SF T cells were actively
dividing and driving a local inflammatory process, as
antigen-specific T cells may be present at frequencies of
fewer than 1/1000 in inflammatory arthropathies [23]. Dif-
ferences in the frequency of dividing cells between patient
subgroups may emerge if greater numbers of patients are
investigated.
Alterations in the microenvironment have been associated
with changes in expression of activation markers in the
absence of proliferation [16]. The SF compartment is rela-
tively hypoxic and this may alter T-cell behaviour in vivo
[24]. Hypoxia has been shown to induce the expression of
the CD71 gene [14,15], and IL-16 has been shown to
increase T-cell expression of CD25 [16]. In the JIA popula-
tion studied, however, no detectable change in the expres-
sion of any activation markers on T cells was observed
after culture in hypoxic conditions, or in the presence of
IL-16. Additionally, overnight culture of SF or PB T cells
with autologous SF did not induce upregulation of the
activation markers. It is likely that many other factors within
the joint, including the presence of synoviocytes, influence
the activation state of synovial T cells.
Research observations of relevance to the aetiology and
pathogenesis of JIA may be masked by the heterogeneity
of the diseases under the umbrella term of JIA [25]. There
was little evidence that different subgroups of JIA in this
study were characterised by different patterns of marker
expression, although the relatively small number of
patients and samples may have obscured subtle changes.
Further study of biochemical indices of cell activation in
larger numbers of JIA patients may help to elucidate differ-
ences in disease pathogenesis in JIA patient populations
with distinct clinical phenotypes.
This study has revealed a number of other interesting find-
ings of potential relevance for T-cell recruitment to the
synovial space. The majority of SF T cells were
CD45RO+CD45RBdull, a finding also made in adults with
rheumatoid arthritis [26,27]. Such highly differentiated
T cells are likely to be recruited to the arthritic joint
because of an intrinsic increase in ability to bind to, and
migrate across, inflamed endothelium [12,28]. When the
T-cell subsets were examined, 74% of SF CD8 T cells
expressed CD45RO, versus 97% of SF CD4 T cells. The
observation that 26% of SF CD8 T cells did not express
CD45RO raises the intriguing possibility that there is a
large intra-articular effector population of CD8 T cells [29]
or that a proportion of the memory CD8 T cells have
reverted to the expression of CD45RA [30]. The influence
of the general inflammatory milieu on T-cell recruitment or
retention in the synovial space has not been extensively
reported. In this study, an association between CD71 and
erythrocyte sedimentation rate was observed. This finding
could indicate that factors governing the acute-phase
response, such as proinflammatory cytokines, influence
the activation state, and possibly the migrating capacity, of
the T cells in SF.
Conclusion
The T cells within the SF of patients with JIA have a phe-
notype that would support selective recruitment from the
blood. Highly differentiated T cells, which have increased
capacity to migrate across inflamed endothelium, may be
selectively recruited to the joint, a process which, of itself,
may alter the expression of activation markers on the cells
in the absence of cell proliferation. This is the first time
that such a T-cell phenotype has been demonstrated in
patients with JIA.
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